LOCALLY ADVANCED UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA

Clinical trials for LOCALLY ADVANCED UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo targets rare, Tough-to-Treat bone cancer

Disease control Ongoing

This study is testing whether a combination of two drugs, belinostat and either guadecitabine or ASTX727, can help control advanced chondrosarcoma, a rare type of bone cancer that cannot be removed by surgery or has spread. The goal is to see if this treatment can shrink tumors o…

Matched conditions: LOCALLY ADVANCED UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

LOCALLY ADVANCED UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA

Get alerted when new LOCALLY ADVANCED UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA trials appear

New drug duo targets rare, Tough-to-Treat bone cancer